|
LOC100129550 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.642400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.526100E-02 |
| Normal-vs-Stage2 |
4.443700E-02 |
| Normal-vs-Stage3 |
8.846800E-01 |
| Normal-vs-Stage4 |
6.265800E-01 |
| Stage1-vs-Stage2 |
2.683000E-01 |
| Stage1-vs-Stage3 |
3.086000E-01 |
| Stage1-vs-Stage4 |
8.558600E-01 |
| Stage2-vs-Stage3 |
9.039500E-02 |
| Stage2-vs-Stage4 |
8.779800E-01 |
| Stage3-vs-Stage4 |
6.580600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.572100E-02 |
| Normal-vs-AfricanAmerican |
2.824000E-02 |
| Normal-vs-Asian |
5.929000E-01 |
| Caucasian-vs-AfricanAmerican |
5.269400E-01 |
| Caucasian-vs-Asian |
8.562000E-01 |
| AfricanAmerican-vs-Asian |
9.585600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.828100E-02 |
| Normal-vs-Female |
3.282900E-03 |
| Male-vs-Female |
5.745900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.000400E-01 |
| Normal-vs-Extreme_Weight |
2.863200E-01 |
| Normal-vs-Obese |
5.215800E-02 |
| Normal-vs-Extreme_Obese |
3.771000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.127800E-01 |
| Normal_Weight-vs-Obese |
7.580600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.472000E-01 |
| Extreme_Weight-vs-Obese |
3.073000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.519200E-01 |
| Obese-vs-Extreme_Obese |
7.390200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.515600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.455550E-03 |
| Normal-vs-Age(61-80Yrs) |
1.774040E-01 |
| Normal-vs-Age(81-100Yrs) |
9.986000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.444800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.311410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.737500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.408400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.377440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.214000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.416900E-04 |
| Normal-VS-Type2 PRCC |
2.236400E-01 |
| Normal-VS-KIRP CIMP |
1.335970E-01 |
| Normal-VS-Unclassified PRCC |
8.827800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.78720000202304E-08 |
| Type1 PRCC-VS-KIRP CIMP |
3.778000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.123200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.700300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.138260E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.118600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.835400E-01 |
| Normal-vs-N1 |
2.781800E-01 |
| Normal-vs-N2 |
5.765800E-01 |
| N0-vs-N1 |
3.243200E-01 |
| N0-vs-N2 |
5.834000E-01 |
| N1-vs-N2 |
6.728600E-01 |
|
|
